Article Details

Ash 2020 – IGM averts disaster, but competition looms

Retrieved on: 2020-12-07 23:15:00

Tags for this article:

Click the tags to see associated articles and topics

Ash 2020 – IGM averts disaster, but competition looms. View article details on hiswai:

Excerpt

Odronextamab and <b>Roche's</b> mosunetuzumab are normal-sized MAbs with differing binding domains on their two Fab arms, epcoritamab is a Duobody ...

Article found on: www.evaluate.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up